Literature DB >> 24925022

IV prenatal nicotine exposure increases the reinforcing efficacy of methamphetamine in adult rat offspring.

Ryan T Lacy1, Amanda J Morgan1, Steven B Harrod2.   

Abstract

BACKGROUND: Maternal smoking during pregnancy is correlated with increased substance use in offspring. Research using rodent models shows that gestational nicotine exposure produces enduring alterations in the neurodevelopment of motivational systems, and that rats prenatally treated with nicotine have altered motivation for drug reinforcement on fixed-ratio (FR) schedules of reinforcement.
OBJECTIVE: The present study investigated methamphetamine (METH) self-administration in adult offspring prenatally exposed to intravenous (IV) nicotine or saline using a progressive-ratio (PR) schedule of reinforcement.
METHODS: Pregnant rats were administered IV prenatal saline (PS) or nicotine (PN; 0.05mg/kg/infusion), 3×/day during gestational days 8-21. At postnatal day 70, offspring acquired a lever-press response for sucrose (26%, w/v; FR1-3). Rats were trained with METH (0.05mg/kg/infusion), and following stable FR responding, animals were tested using a progressive-ratio (PR) schedule for three different doses of METH (0.005, 0.025, and 0.05mg/kg/infusion).
RESULTS: METH infusion, active lever presses, and the ratio breakpoint are reported. PN-exposed animals exhibited more METH-maintained responding than PS controls, according to a dose×prenatal treatment interaction (e.g., infusions). PN rats self-administered more METH infusions between the range of 0.025 and 0.05, but not for the 0.005mg/kg/infusion dose.
CONCLUSIONS: IV PN-exposure produced enhanced motivation to self-administer METH. These findings indicate that pregnant women who smoke tobacco may impart neurobiological changes in offspring's motivational systems that render them increasingly vulnerable to drug abuse during adulthood.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Methamphetamine; Motivation; Nicotine; Prenatal; Rat; Self-administration

Mesh:

Substances:

Year:  2014        PMID: 24925022      PMCID: PMC4103028          DOI: 10.1016/j.drugalcdep.2014.05.010

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  36 in total

1.  Increased nicotine self-administration following prenatal exposure in female rats.

Authors:  Edward D Levin; Susan Lawrence; Ann Petro; Kofi Horton; Frederic J Seidler; Theodore A Slotkin
Journal:  Pharmacol Biochem Behav       Date:  2006-12-28       Impact factor: 3.533

Review 2.  Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy.

Authors:  N R Richardson; D C Roberts
Journal:  J Neurosci Methods       Date:  1996-05       Impact factor: 2.390

3.  Intravenous gestational nicotine exposure results in increased motivation for sucrose reward in adult rat offspring.

Authors:  Ryan T Lacy; Lauren L Hord; Amanda J Morgan; Steven B Harrod
Journal:  Drug Alcohol Depend       Date:  2012-02-27       Impact factor: 4.492

4.  Low birth weight and neonatal mortality rate related to maternal smoking and socioeconomic status.

Authors:  G W Comstock; F K Shah; M B Meyer; H Abbey
Journal:  Am J Obstet Gynecol       Date:  1971-09       Impact factor: 8.661

5.  Effects of maternal intravenous nicotine administration on locomotor behavior in pre-weanling rats.

Authors:  Mark G LeSage; Erianne Gustaf; Matthew B Dufek; Paul R Pentel
Journal:  Pharmacol Biochem Behav       Date:  2006-12-04       Impact factor: 3.533

6.  Establishing a nicotine threshold for addiction. The implications for tobacco regulation.

Authors:  N L Benowitz; J E Henningfield
Journal:  N Engl J Med       Date:  1994-07-14       Impact factor: 91.245

7.  Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species.

Authors:  R R Holson; B Pearce
Journal:  Neurotoxicol Teratol       Date:  1992 May-Jun       Impact factor: 3.763

8.  Gestational IV nicotine produces elevated brain-derived neurotrophic factor in the mesocorticolimbic dopamine system of adolescent rat offspring.

Authors:  Steven B Harrod; Ryan T Lacy; Jun Zhu; Benjamin A Hughes; Marla K Perna; Russell W Brown
Journal:  Synapse       Date:  2011-12       Impact factor: 2.562

9.  Hyperactivity induced by prenatal nicotine exposure is associated with an increase in cortical nicotinic receptors.

Authors:  Y Tizabi; E J Popke; M A Rahman; S M Nespor; N E Grunberg
Journal:  Pharmacol Biochem Behav       Date:  1997-09       Impact factor: 3.533

10.  Offspring of Prenatal IV Nicotine Exposure Exhibit Increased Sensitivity to the Reinforcing Effects of Methamphetamine.

Authors:  Steven B Harrod; Ryan T Lacy; Amanda J Morgan
Journal:  Front Pharmacol       Date:  2012-06-18       Impact factor: 5.810

View more
  5 in total

1.  Female Sprague-Dawley rats display greater appetitive and consummatory responses to alcohol.

Authors:  Steven J Nieto; Therese A Kosten
Journal:  Behav Brain Res       Date:  2017-03-30       Impact factor: 3.332

2.  Intravenous Prenatal Nicotine Exposure Alters METH-Induced Hyperactivity, Conditioned Hyperactivity, and BDNF in Adult Rat Offspring.

Authors:  Ryan T Lacy; Russell W Brown; Amanda J Morgan; Charles F Mactutus; Steven B Harrod
Journal:  Dev Neurosci       Date:  2016-06-11       Impact factor: 2.984

Review 3.  Prenatal influences on temperament development: The role of environmental epigenetics.

Authors:  Maria A Gartstein; Michael K Skinner
Journal:  Dev Psychopathol       Date:  2017-12-12

4.  HIV-1 proteins dysregulate motivational processes and dopamine circuitry.

Authors:  Sarah J Bertrand; Charles F Mactutus; Steven B Harrod; Landhing M Moran; Rosemarie M Booze
Journal:  Sci Rep       Date:  2018-05-18       Impact factor: 4.379

Review 5.  The Adverse Effects of Prenatal METH Exposure on the Offspring: A Review.

Authors:  Jia-Hao Li; Jia-Li Liu; Kai-Kai Zhang; Li-Jian Chen; Jing-Tao Xu; Xiao-Li Xie
Journal:  Front Pharmacol       Date:  2021-07-14       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.